AMRS - Amyris GAAP EPS of -$0.44 misses by $0.15 revenue of $65.21M misses by $16.32M
- Amyris press release ( NASDAQ: AMRS ): Q2 GAAP EPS of -$0.44 misses by $0.15 .
- Revenue of $65.21M (+24.6% Y/Y) misses by $16.32M .
- "We are moving beyond the period of significant investment and the constraints on our ingredients production capacity. We are entering the second half with a consumer business that we expect to deliver accelerated growth year-over-year, and a $15 million ingredient backlog for shipping in the second half. We have a robust outlook for the remainder of the year and our guidance remains intact. We have visibility to over $700 million of funding and cash inflow from earnouts with $200 million expected during the third quarter. We have built the leading clean beauty consumer brands, which are accelerating the reach of our Lab-to-Market technology. We are just getting started as the world's leading developer and producer of clean, sustainable chemistry."
For further details see:
Amyris GAAP EPS of -$0.44 misses by $0.15, revenue of $65.21M misses by $16.32M